Solventum Corporation

€70.97
EUR
Last updated on --.
24h volume2.49M
24h highest71.2044 EUR
24h lowest67.6136 EUR
24h Price movement+5.18%

SOLV recent prices

24 Hours
+5.18%+€3.496
30 days
+15.48%+€9.460
60 days
+29.61%+€16.12
90 days
+12.89%+€7.706

Key data

Previous close67.4758 EUR
Market cap11.18B EUR
Volume2.49M
P/E ratio9.060000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)7.1213 EUR
Net income (FY)1.23B EUR
Revenue (FY)7.11B EUR
Last report dateMay 5, 2026

About Solventum Corporation

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
HeadquartersEAGAN
Employees (FY)20.00K
Revenue per employee (FY)355.72K EUR
Net income per employee (FY)61.65K EUR
Listed onNew York Stock Exchange
Official website

SOLV conversion tables

SOLVSOLV
EUREUR
0.5 SOLV35.48 EUR
1 SOLV70.97 EUR
5 SOLV354.85 EUR
10 SOLV709.71 EUR
EUREUR
SOLVSOLV
0.5 EUR0.007045 SOLV
1 EUR0.01409 SOLV
5 EUR0.07045 SOLV
10 EUR0.1409 SOLV

FAQ

SOLV is trading at €70.97, +5.18% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SOLV stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SOLV is currently trading at €70.97, +5.18% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SOLV price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SOLV's P/E ratio is currently 9.060000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SOLV; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SOLV's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Solventum Corporation's market cap is currently 11.18B EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.49M
24h highest71.2044 EUR
24h lowest67.6136 EUR
24h Price movement+5.18%
SOLVSOLV
EUREUR
Start trade with SOLV Perpetual